Gal-3 overexpression in the AML cell line by hBM-MSCs enhanced β-catenin expression at the protein but not mRNA level in the AML cell line, which implies that Gal-3 overexpression stabilized β-catenin in the AML cell line, possibly by preventing its degradation. The gene discussed is LGALS3; the disease is acute myeloid leukemia.